analyst

NASDAQ · CTMX
CytomX Therapeutics, Inc.
Healthcare · Biotechnology
$1.99
Down-$0.06 (-2.70%)
Updated Nov 17, 2026, 5:42 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 686.8M
- P/E ratio
- 23.88
- Dividend yield
- 0.00%
- 52-week range
- $1.90 – $8.21
- Volume
- 2.6M
- Avg. volume
- 3.54M
Price performance · CTMX
CTMX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 16, 2026
CTMX closed at $1.99 after 21 trading sessions, down 15.17% for the selected period.
- Last close
- $1.99
- Period change
- -15.17%
- Period low
- $1.98
- Period high
- $2.51
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | $2.02 | $2.08 | $1.94 | $1.985 | 2.6M |
| Nov 13, 2026 | $2.02 | $2.1252 | $1.96 | $2.04 | 2.72M |
| Nov 12, 2026 | $2.15 | $2.18 | $2.03 | $2.04 | 3.16M |
| Nov 11, 2026 | $1.99 | $2.17 | $1.96 | $2.13 | 4.99M |
| Nov 10, 2026 | $1.99 | $2.02 | $1.90 | $1.98 | 16.65M |
| Nov 9, 2026 | $2.24 | $2.28 | $1.95 | $1.98 | 12.91M |
| Nov 6, 2026 | $2.24 | $2.27 | $2.1201 | $2.19 | 2.73M |
| Nov 5, 2026 | $2.35 | $2.35 | $2.11 | $2.14 | 3.86M |
| Nov 4, 2026 | $2.26 | $2.36 | $2.175 | $2.35 | 6.59M |
| Nov 3, 2026 | $2.24 | $2.32 | $2.155 | $2.18 | 3.41M |
| Nov 2, 2026 | $2.36 | $2.39 | $2.14 | $2.23 | 9.47M |
| Oct 30, 2026 | $2.28 | $2.36 | $2.21 | $2.34 | 4.94M |
| Oct 29, 2026 | $2.38 | $2.42 | $2.25 | $2.29 | 4.63M |
| Oct 28, 2026 | $2.28 | $2.385 | $2.25 | $2.36 | 4.08M |
| Oct 27, 2026 | $2.21 | $2.36 | $2.16 | $2.31 | 3.73M |
| Oct 26, 2026 | $2.31 | $2.33 | $2.18 | $2.225 | 5.22M |
| Oct 23, 2026 | $2.41 | $2.42 | $2.305 | $2.32 | 4.37M |
| Oct 22, 2026 | $2.38 | $2.47 | $2.37 | $2.44 | 2.44M |
| Oct 21, 2026 | $2.525 | $2.61 | $2.39 | $2.40 | 3.11M |
| Oct 20, 2026 | $2.36 | $2.55 | $2.34 | $2.51 | 4.1M |
| Oct 19, 2026 | $2.31 | $2.35 | $2.24 | $2.34 | 2.05M |
Latest CTMX news
The latest Smart Investors Daily articles mentioning CTMX.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…

